Patrick Yang, Ph.D.
Patrick Y. Yang, Ph.D. has served as a member of our Board since October 2018. Dr. Yang is a co-founder and Executive Vice Chairman of National Resilience, Inc., a privately held biomanufacturing technology company. Dr. Yang served as Executive Vice President and Special Advisor of Juno Therapeutics, Inc. from September 2017 to January 2019. Since 2013, Dr. Yang has served as a biotechnology and biopharmaceutical industry consultant. From January 2010 to March 2013, Dr. Yang served as Executive Vice President and Global Head of Technical Operations for F. Hoffmann-La Roche Ltd., a healthcare company, where he was responsible for the company’s pharmaceutical process development, engineering, quality, technical regulatory, supply chain, and manufacturing plants. Before joining Roche, Dr. Yang served in roles of increasing responsibility at each of Genentech, Inc., a biotechnology company, Merck & Co., Inc., a public pharmaceutical company, General Electric Company, a public industrial company, and Life Systems, Inc., a life science research and development company, during which time he developed significant experience with pharmaceuticals and biotechnology manufacturing, engineering, technology, and supply chain management. Dr. Yang serves on the boards of directors of Codexis, Inc., a public biotechnology company, PharmaEssentia Corp., a public biopharmaceutical company in Taiwan, and Polaris Group, a public biotechnology company in Taiwan. Dr. Yang previously served on the boards of directors of Amyris, Inc., a public biotechnology company, and Andeavor, Inc. (formerly Tesoro Corporation), a public independent petroleum refining and marketing company. Dr. Yang received his Ph.D. in Engineering from the Ohio State University, his M.Sc. in Electrical Engineering from the University of Cincinnati, and his B.S. in Engineering from the National Chiaotung University in Taiwan.